Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various ...

Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

A Phase 1 trial found an infusion of mesenchymal stem cells lowered auto-reactive immune cell levelss in lupus patients; a Phase 2 study is starting in US.

How clinical trials into lupus nephritis define their requirements for patient eligibility are too strict, leaving many people with active and severe disease ineligible for participation, according to ...

To help you learn a little bit more about what you should and shouldn’t be eating, we’ve put together a list of foods that you might want to avoid if you’re a lupus patient (source: healthline.com): ...

Lupuzor (rigerimod, or IPP-201101) combined with standard therapy did not demonstrate a statistically significant response rate in systemic lupus erythematosus (SLE) patients over standard care alone, ...

This year, let's flip old assumptions about living with lupus on their head, writes columnist Candace Semien.

Ventus Therapeutics plans to develop a new treatment candidate for lupus and other inflammatory diseases marked by the activation of the type 1 interferon immune system pathway, the company recently ...

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

In men that difference was lesser. Male patients with lupus lived a median of 61 years, and those in the public at large to age 73, a median 12-year difference. While septicemia and hypertension were ...

A lab study suggests that overproduction of a molecule called IFN-I, which promotes inflammation, may be due to mitochondrial injury, like oxidative stress.